LXN CORP.'S FRUCTOSAMINE MONITOR MAY REQUIRE PRESCRIPTION FOR HOME USE -- FDA PANEL; 510(K) SUPPORTS SUBSTANTIAL EQUIVALENCE TO LAB-USE DEVICE, GROUP AGREES